Evidence map›Paper›PMID 40168369›Full record

ArticlePloS one2025

Comparison of HIV prevention indicators among adolescent girls and young women in DREAMS and non-DREAMS intervention districts in Uganda.

Norah Namuwenge, Derrick Kimuli, Rebecca N Nsubuga, Timothy Sserunga, Sheila Nyakwezi, Jaffer Byawaka, Garoma Kena, Solome Sevume, Norbert Mubiru, Barbara Amuron and 1 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Norah NamuwengeSocial & Scientific Systems, a DLH Holdings company, United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.
Derrick KimuliSocial & Scientific Systems, a DLH Holdings company, United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.ORCID 0000-0002-5302-7077
Rebecca N NsubugaSocial & Scientific Systems, a DLH Holdings company, United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.
Timothy SserungaSocial & Scientific Systems, a DLH Holdings company, United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.
Sheila NyakweziThe United States Agency for International Development Uganda, US Mission Compound - South Wing, Kampala, Uganda.
Jaffer ByawakaThe United States Agency for International Development Uganda, US Mission Compound - South Wing, Kampala, Uganda.
Garoma KenaThe United States Agency for International Development Uganda, US Mission Compound - South Wing, Kampala, Uganda.
Solome SevumeThe United States Agency for International Development Uganda, US Mission Compound - South Wing, Kampala, Uganda.
Norbert MubiruThe United States Agency for International Development Uganda, US Mission Compound - South Wing, Kampala, Uganda.
Barbara AmuronSocial & Scientific Systems, a DLH Holdings company, United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.
Daraus BukenyaSocial & Scientific Systems, a DLH Holdings company, United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In sub-Saharan Africa, a significant number of new human immunodeficiency virus (HIV) infections occur among adolescent girls and young women (AGYW). The 2023 Uganda Annual Spectrum estimates indicated that about one-third of all new HIV infections are among AGYW. In 2016, the Ministry of Health in partnership with the United States President's Emergency Plan for AIDS Relief (PEPFAR) initiated the Determined, Resilient, Empowered, AIDS-Free, Mentored and Safe (DREAMS) program to reduce the vulnerability of AGYW to HIV by offering various direct and indirect HIV-related prevention services. These services influence the level of various HIV prevention indicators in the age group. This study aimed to compare these levels. The study was a secondary analysis of pooled Lot Quality Assurance Sampling (LQAS) survey data collected in DREAMS and non-DREAMS districts during 2021 and 2022. Fifteen HIV prevention indicators were independently compared between 8 DREAMS and 8 non-DREAMS districts. Chi-square tests were used to assess the significance in the differences. Of the 9,290 records of AGYW reviewed, 52.40% were of AGYW residing in DREAMS districts. Between DREAMS and non-DREAMS districts, significant differences in level of knowledge of HIV prevention methods (25.60% versus 14.63%, p < 0.001), condom use (58.99% versus 48.33%, p < 0.001), knowledge of HIV testing points (93.43% versus 92.38%, p = 0.049), having multiple sex partners (15.28% versus 10.11%, p < 0.001), condom use (58.99% versus 48.33%, p < 0.001), HIV testing (84.86% versus 82.00%, p < 0.001) and multiple sex partners (15.28% versus 10.11%, p < 0.001) among other indictors. AGYW in DREAMS districts had better outcomes for all indicators except multiple sex partners. Although this factor likely contributed to the initial selection of DREAMS-intervention districts, its persistence may continue to influence overall efforts towards the reduction of HIV prevalence. Moreover, this potentially mitigates the benefits from other better performing indicators.

Indexed as

HIV InfectionsAdolescentAdultFemaleHumansSexual BehaviorUgandaYoung Adult

Identifiers

PMID40168369
PMCPMC11960884

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.